Work

Thalidomide has limited single‐agent activity in relapsed or refractory indolent non‐Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B

Year: 2008

Type: article

Study design: Clinical Trial

Source: British Journal of Haematology

DOI: 10.1111/j.1365-2141.2007.06937.x

Authors: Sonali M. Smith, David Grinblatt, Jeffrey L. Johnson, Donna Niedzwiecki, David Rizzieri, Nancy L. Bartlett, Bruce D. Cheson, for the Cancer and Leukemia Group B

Institutions: University of Chicago, Duke Medical Center, Washington University in St. Louis, Georgetown University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2020301828

FWCI: 2.527

Cites: 35

Cited by: 29

Related to: 10